Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The MMACHC/MMADHC trafficking complex is a 1:1 heterodimeric protein assembly essential for the intracellular processing and distribution of vitamin B12 (cobalamin) [1, 10]. It consists of the Methylmalonic aciduria and homocystinuria type C protein (MMACHC), which acts as a multifunctional enzyme to dealkylate or decyanate incoming cobalamin, and the Methylmalonic aciduria and homocystinuria type D protein (MMADHC), which serves as a trafficking chaperone [1, 2, 11]. Together, they facilitate the conversion of dietary cobalamin into a common cob(II)alamin intermediate and partition it toward the synthesis of methylcobalamin in the cytosol and adenosylcobalamin in the mitochondria [1, 8, 13]. These cofactors are vital for the activity of methionine synthase and methylmalonyl-CoA mutase, respectively [2, 11, 16]. Genetic mutations in either component of the complex result in severe inborn errors of metabolism, such as cblC and cblD deficiencies, characterized by the accumulation of methylmalonic acid and homocysteine [3, 12, 15]. While current management relies on high-dose hydroxocobalamin and metabolic supplements, the complex is a primary target for emerging genomic therapies, including AAV-mediated gene replacement and mRNA-based interventions, aimed at restoring functional cobalamin trafficking and preventing progressive neurological and ocular complications [24, 33, 34].
The complex facilitates the intracellular processing of cobalamin derivatives into active cofactors and their subsequent delivery to target enzymes [1, 8, 13].
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Methylmalonic aciduria and homocystinuria type C and D protein complex (MMACHC/MMADHC complex).